The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
Open accessAbstract
The clinical course of autoimmune and infectious disease varies greatly, even between individuals with the same condition. An understanding of the molecular basis for this heterogeneity could lead to significant improvements in both monitoring and treatment. During chronic infection the process of T-cell exhaustion inhibits the immune response, facilitating viral persistence. Here we show that a transcriptional signature reflecting CD8 T-cell exhaustion is associated with poor clearance of chronic viral infection, but conversely predicts better prognosis in multiple autoimmune diseases. The development of CD8 T-cell exhaustion during chronic infection is driven both by persistence of antigen and by a lack of accessory 'help' signals. In autoimmunity, we find that where evidence of CD4 T-cell co-stimulation is pronounced, that of CD8 T-cell exhaustion is reduced. We can reproduce the exhaustion signature by modifying the balance of persistent stimulation of T-cell antigen receptors and specific CD2-induced co-stimulation provided to human CD8 T cells in vitro, suggesting that each process plays a role in dictating outcome in autoimmune disease. The 'non-exhausted' T-cell state driven by CD2-induced co-stimulation is reduced by signals through the exhaustion-associated inhibitory receptor PD-1, suggesting that induction of exhaustion may be a therapeutic strategy in autoimmune and inflammatory disease. Using expression of optimal surrogate markers of co-stimulation/exhaustion signatures in independent data sets, we confirm an association with good clinical outcome or response to therapy in infection (hepatitis C virus) and vaccination (yellow fever, malaria, influenza), but poor outcome in autoimmune and inflammatory disease (type 1 diabetes, anti-neutrophil cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus, idiopathic pulmonary fibrosis and dengue haemorrhagic fever). Thus, T-cell exhaustion plays a central role in determining outcome in autoimmune disease and targeted manipulation of this process could lead to new therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Consistently, a CD8 + Tcell transcriptional profile of exhaustion correlates with beneficial outcome in AID 35,59 and response to immunotherapies. 60”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Cited by
Sorted by citations
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 2,054
Fraietta, J. A., Lacey, S. F., Orlando, E. J., Pruteanu-Malinici, I., Gohil, M., Lundh, S., Boesteanu, A. C., Wang, Y., O’Connor, R. S., Hwang, W.-T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0010-1 · Cited by 1,785
Blank, C. U., Haining, W. N., Held, W., Hogan, P. G., Kallies, A., Lugli, E., Lynn, R. C., Philip, M., Rao, A., Restifo, N. P., et al. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0221-9 · Cited by 1,603
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902226 · Cited by 1,189
Beltra, J., Manne, S., Abdel-Hakeem, M. S., Kurachi, M., Giles, J. R., Chen, Z., Casella, V., Ngiow, S. F., Khan, O., Huang, Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.014 · Cited by 1,139
“Conversely, as exhaustion gets more severe, clinical symptoms of autoimmunity decrease (McKinney et al., 2015).”
BackgroundSun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,153
Kitching, A. R., Anders, H., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R. W., Kullman, J. A., Lyons, P., Merkel, P. A., Savage, C. O. S., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0204-y · Cited by 1,009
Self-citationAlmaani, S. J., Meara, A. S., & Rovin, B. H. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05780616 · Cited by 941
“Finally, a recent investigation tied concepts important for viral immunity to autoimmunity, providing insights into relapsing autoimmune disease (46), a problem that is particularly relevant to LN.”
BackgroundThe immune cell landscape in kidneys of patients with lupus nephritis
the Accelerating Medicines Partnership in SLE network, Arazi, A., Rao, D. A., Berthier, C. C., Davidson, A., Liu, Y., Hoover, P., Chicoine, A. T., Eisenhaure, T., Jonsson, A. H., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0398-x · Cited by 835
Pathway paradigms revealed from the genetics of inflammatory bowel disease
Graham, D. B., & Xavier, R. J. (2020) · Nature · doi:10.1038/s41586-020-2025-2 · Cited by 801
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Banchereau, R., Hong, S., Cantarel, B. L., Baldwin, N. E., Baisch, J. M., Edens, M., Cepika, A., Acs, P., Turner, J., Anguiano, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.008 · Cited by 751
“Biomarkers that can predict occurrence and frequency of flares will be of great value in the clinic (McKinney et al., 2015).”
Autoimmunity and organ damage in systemic lupus erythematosus
Tsokos, G. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0677-6 · Cited by 589
Mieli‐Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., Lohse, A. W., & Montaño‐Loza, A. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.17 · Cited by 485
Bense, R. D., Sotiriou, C. P., Piccart, M. J., Haanen, J. B. A. G., van Vugt, M. A. T. M., de Vries, E. G. E., Schröder, C. P., & Fehrmann, R. S. N. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw192 · Cited by 380
Belk, J. A., Yao, W., Ly, N., Freitas, K. A., Chen, Y.-T., Shi, Q., Valencia, A. M., Shifrut, E., Kale, N., Yost, K. E., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.06.001 · Cited by 382
“, 2006), T cell exhaustion is now appreciated to occur in diverse disease settings, including cancer and autoimmune disease (McKinney et al., 2015; McLane et al., 2019).”
BackgroundT Cells in Fibrosis and Fibrotic Diseases
Zhang, M., & Zhang, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01142 · Cited by 344
“T cells can regulate the pulmonary fibrosis outcome through cAMP-regulated chloride channels (11), Fas-Fas ligand (FasL) interactions (12), or T cell exhaustion (13).”
BackgroundEpigenetic regulation of T cell exhaustion
Belk, J. A., Dániel, B., & Satpathy, A. T. (2022) · Nature Immunology · doi:10.1038/s41590-022-01224-z · Cited by 346
Bengsch, B., Ohtani, T., Khan, O., Setty, M. N., Manne, S., O’Brien, S., Gherardini, P. F., Herati, R. S., Huang, A. C. C., Chang, K., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.026 · Cited by 313
“Tex cells have also been implicated in autoimmune diseases where transcriptional signatures of Tex cells are enriched in patients with less severe disease (McKinney et al., 2015).”
BackgroundHowell, K. J., Kraiczy, J., Nayak, K., Gasparetto, M., Ross, A., Lee, C., Mak, T. N., Koo, B., Kumar, N., Lawley, T. D., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.10.007 · Cited by 329
“We decided to utilize WGCNA, which has been successfully applied to both RNAseq and DNAm datasets, allowing identification and correlation of individual gene modules with clinical parameters.(40) Results are highly encouraging because we discovered a number of gene expression modules that correlated strongly with the…”
MethodNoor, N. M., Lee, J. C., Bond, S. J., Dowling, F., Brezina, B., Patel, K., Ahmad, T., Banim, P. J. R., Berrill, J., Cooney, R. M., et al. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00034-7 · Cited by 336
“27,28 Care had been taken during biomarker develop ment to prevent over-fitting and independently validate associations with clinical outcome in two real-world cohorts.”
ResultSelf-citationLee, J. C., Biasci, D., Roberts, R., Gearry, R. B., Mansfield, J. C., Ahmad, T., Prescott, N. J., Satsangi, J., Wilson, D. C., Jostins, L., et al. (2017) · Nature Genetics · doi:10.1038/ng.3755 · Cited by 304
Self-citationRethinking peripheral T cell tolerance: checkpoints across a T cell’s journey
ElTanbouly, M. A., & Noelle, R. J. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00454-2 · Cited by 282
Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
Makarious, D., Horwood, K., & Coward, J. I. G. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.041 · Cited by 263
“With respect to PD-1, its overexpression is associated with favourable outcomes in autoimmune diseases as it potentiates CD8 T-cell exhaustion; hence, it is feasible that PD-1 inhibition could result in the exacerbation of symptoms in patients with pre-existing MG [31,32].”
BackgroundVentham, N. T., Kennedy, N. A., Adams, A. T., Kalla, R., Heath, S. C., O'Leary, K. E., Drummond, H., Lauc, G., Campbell, H., McGovern, D. P. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms13507 · Cited by 255
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis
Corridoni, D., Antanaviciute, A., Gupta, T., Fawkner-Corbett, D., Aulicino, A., Jagielowicz, M., Parikh, K., Repapi, E., Taylor, S. L., Ishikawa, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1003-4 · Cited by 257
Collier, J. L., Weiss, S. A., Pauken, K. E., Sen, D. R., & Sharpe, A. H. (2021) · Nature Immunology · doi:10.1038/s41590-021-00949-7 · Cited by 237
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes
Long, S. A., Thorpe, J., DeBerg, H. A., Gersuk, V., Eddy, J. A., Harris, K. M., Ehlers, M., Herold, K. C., Nepom, G. T., & Linsley, P. S. (2016) · Science Immunology · doi:10.1126/sciimmunol.aai7793 · Cited by 250
LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation
Joller, N., Anderson, A. C., & Kuchroo, V. K. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.010 · Cited by 296
Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis
Zhang, H., Watanabe, R., Berry, G. J., Vaglio, A., Liao, Y. J., Warrington, K. J., Goronzy, J. J., & Weyand, C. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616848114 · Cited by 250
“signatures was predictive of clinical outcomes in infectious versus autoimmune diseases (54).”
BackgroundSuppression by TFR cells leads to durable and selective inhibition of B cell effector function
Sage, P. T., Ron‐Harel, N., Juneja, V. R., Sen, D. R., Maleri, S., Sungnak, W., Kuchroo, V. K., Haining, W. N., Chevrier, N., Haigis, M. C., et al. (2016) · Nature Immunology · doi:10.1038/ni.3578 · Cited by 247
The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
Governa, V., Trella, E., Mele, V., Tornillo, L., Amicarella, F., Cremonesi, E., Muraro, M. G., Xu, H., Droeser, R. A., Däster, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2047 · Cited by 237
“To further characterize neutrophil-mediated costimulation of CD8þ T cells, we evaluated phenotypic profiles of lymphocytes activated by optimal anti-CD3 concentrations and CD28 in the presence or absence of granulocytes for 5 days, thus, beyond time points usually considered for detection of maximal proliferation (31).”
BackgroundMethodResultRheumatic immune-related adverse events from cancer immunotherapy
Calabrese, L. H., Calabrese, C. M., & Cappelli, L. C. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0074-9 · Cited by 237
T cells in Systemic Lupus Erythematosus
Suárez‐Fueyo, A., Bradley, S. J., & Tsokos, G. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.001 · Cited by 230
“Induction of exhaustion has been proposed as therapy for autoimmune disease, as an exhaustion transcriptome profile marks patients with better clinical outcomes [10].”
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
Schnell, A., Bod, L., Madi, A., & Kuchroo, V. K. (2020) · Cell Research · doi:10.1038/s41422-020-0277-x · Cited by 234
“Additionally, a transcriptional signature of T-cell exhaustion is associated with a favorable clinical outcome in multiple human autoimmune diseases.(31) Based on these data, promoting T-cell exhaustion could be beneficial in autoimmunity, and provides a novel therapeutic approach for inhibiting autoimmunity(31,118) (…”
BackgroundT cell Allorecognition Pathways in Solid Organ Transplantation
Siu, J. H. Y., Surendrakumar, V., Richards, J. A., & Pettigrew, G. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02548 · Cited by 223
“It has garnered much attention recently, because it is perhaps not the propensity to trigger self-reactive responses, but the ability, or otherwise, to counter their progression through development of an exhaustive state that may ultimately determine outcomes for autoimmune disease (71, 78).”
BackgroundLiu, L. L., Landskron, J., Ask, E. H., Enqvist, M., Sohlberg, E., Traherne, J. A., Hammer, Q., Goodridge, J. P., Larsson, S., Jayaraman, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.005 · Cited by 230
“It will be of interest to explore whether CD2 costimulation of CD16-driven responses influence the functional reprogramming of the cell during expansion in a fashion similar to that noted in the context of T cell exhaustion in autoimmunity and infection (McKinney et al., 2015).”
ResultThe immunology of type 1 diabetes
Herold, K. C., Delong, T., Perdigoto, A. L., Biru, N., Brusko, T. M., & Walker, L. S. K. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-023-00985-4 · Cited by 241
“…cells from treated patients, extend the observational studies that slow rates of sponta-neous disease in at-risk individuals correlate with T cell exhaustion signatures identified in treated patients by expression of an EOMES signature and the expression of TIGIT and KLRG1 on CD8 + T cells 206 .”
Rivino, L., Bert, N. L., Gill, U. S., Kunasegaran, K., Cheng, Y., Tan, D., Becht, É., Hansi, N. K., Foster, G. R., Su, T., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci92812 · Cited by 208
“Furthermore, it was recently reported that a transcriptional T cell signature that is linked to CD8+ T cell exhaustion and CD4+ T cell costimulation can predict the outcome of chronic viral infection (12).”
BackgroundWillsmore, Z. N., Coumbe, B. G. T., Crescioli, S., Reci, S., Gupta, A., Harris, R. J. C., Chenoweth, A. M., Chauhan, J., Bax, H. J., McCraw, A. J., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202048747 · Cited by 216
C1q restrains autoimmunity and viral infection by regulating CD8 + T cell metabolism
Ling, G. S., Crawford, G., Buang, N., Bartok, I., Tian, K., Thielens, N. M., Bally, I., Harker, J. A., Ashton-Rickardt, P. G., Rutschmann, S., et al. (2018) · Science · doi:10.1126/science.aao4555 · Cited by 199
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
Catakovic, K., Klieser, E., Neureiter, D., & Geisberger, R. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-016-0160-z · Cited by 207
“In line with that, presence of exhausted T cells in patients with autoimmune diseases correlates with favorable prognosis [18].”
BackgroundHerazo-Maya, J. D., Sun, J., Molyneaux, P. L., Li, Q., Villalba, J. A., Tzouvelekis, A., Lynn, H., Juan-Guardela, B. M., Risquez, C., Osorio, J. C., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30349-1 · Cited by 175
A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy
Mi, Y., Smith, C. C., Yang, F., Qi, Y., Roche, K. C., Serody, J. S., Vincent, B. G., & Wang, A. Z. (2018) · Advanced Materials · doi:10.1002/adma.201706098 · Cited by 200
Zhu, H., Galdos, F. X., Lee, D., Waliany, S., Huang, Y. V., Ryan, J., Dang, K., Neal, J. W., Wakelee, H. A., Reddy, S. A., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056730 · Cited by 192
A blood-based prognostic biomarker in IBD
Biasci, D., Lee, J. C., Noor, N. M., Pombal, D., Hou, M., Lewis, N. R., Ahmad, T., Hart, A. L., Parkes, M., McKinney, E. F., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318343 · Cited by 191
Self-citationHuman leukocyte antigen variation is associated with adverse events of checkpoint inhibitors
Hasan Ali, O., Berner, F., Bomze, D., Fässler, M., Diem, S., Cozzio, A., Jörger, M., Früh, M., Driessen, C., Lenz, T. L., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.11.009 · Cited by 187
“%) patients were treated with antiePD-1 (nivolumab or pembrolizumab) or anti-PD-L1 (atezolizumab) treatment alone.”
InfluentialThe advent of immune stimulating CAFs in cancer
Tsoumakidou, M. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00549-7 · Cited by 192
Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease
Uhlig, H. H., & Powrie, F. M. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053055 · Cited by 174
Sokołowska, M., Łukasik, Z. M., Agache, I. O., Akdiş, C. A., Akdiş, D., Akdiş, M., Barcik, W., Brough, H. A., Eiwegger, T., Eljaszewicz, A., et al. (2020) · Allergy · doi:10.1111/all.14462 · Cited by 170
Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression
Wiedeman, A. E., Muir, V. S., Rosasco, M. G., DeBerg, H. A., Presnell, S., Haas, B., Dufort, M. J., Speake, C., Greenbaum, C. J., Serti, E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126595 · Cited by 168
“By contrast, increased CD8+ T cell exhaustion is associated with a beneficial response to therapy in recent-onset T1D (20, 50) as well as slower disease progression or a better prognosis in Crohn’s disease, SLE, and vasculitis (51, 52).”
BackgroundFunctional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
Dixon, K. O., Schorer, M., Nevin, J. T., Etminan, Y., Amoozgar, Z., Kondo, T., Kurtuluş, S., Kassam, N., Sobel, R. A., Fukumura, D., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700407 · Cited by 164
“In this context, the role that coinhibitory molecules may play in regulating progression in autoimmune diseases in humans has been indicated in a large cohort of patients suffering with multiple autoimmune diseases (17).”
BackgroundKatsuyama, E., Suárez‐Fueyo, A., Bradley, S. J., Mizui, M., Marín, A. V., Mulki, L., Krishfield, S., Malavasi, F., Yoon, J. H., Sui, S. J. H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.014 · Cited by 166
“It should be noted that blockade of PD1/PDL1 in cancer patients with SLE may cause de novo appearance of systemic autoimmunity (Naidoo et al., 2016), and T cell exhaustion may favor autoimmunity albeit worsen viral infections (McKinney et al., 2015).”
Kong, R., Wang, N., Han, W., Bao, W., & Lu, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma1220-815rrr · Cited by 164
Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted
Tilstra, J. S., Avery, L., Menk, A. V., Gordon, R. A., Smita, S., Kane, L. P., Chikina, M., Delgoffe, G. M., & Shlomchik, M. J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120859 · Cited by 149
“While, to our knowledge, exhaustion of T cells within target organs has not been linked to autoimmunity, a recent landmark study correlated the presence of exhausted CD8+ T cells in the peripheral blood with prolonged flare-free survival in lupus and antineutrophil cytoplasmic antibody (ANCA) vasculitis (65).”
Li, M., Guo, W., Dong, Y., Wang, X., Dai, D., Liu, X., Wu, Y., Li, M., Zhang, W., Zhou, H., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580237 · Cited by 157
“Programmed death-1 (PD-1) and CD244 are immunoregulatory receptors found onmany immune cell types, including NK cells and T cells, and that represent potential therapeutic targets (21, 22).”
BackgroundCarbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30163-8 · Cited by 155
Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma
Molodtsov, A. K., Khatwani, N., Vella, J. L., Lewis, K. A., Zhao, Y., Han, J., Sullivan, D. E., Searles, T. G., Preiss, N. K., Shabaneh, T. B., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.019 · Cited by 157
Exhaustion of CAR T cells: potential causes and solutions
Kouro, T., Himuro, H., & Sasada, T. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03442-3 · Cited by 156
“While it would be indispensable to stop immune responses at certain stages to prevent adverse effects such as autoimmune diseases [17], it also prevents the effects of cancer immunotherapy; tumor infiltrating T cells frequently become exhausted by excessive antigen stimulation and/or inhibitory TME [18].”
BackgroundCatalina, M. D., Owen, K. A., Labonte, A. C., Grammer, A. C., & Lipsky, P. E. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102359 · Cited by 146
SLE: Another Autoimmune Disorder Influenced by Microbes and Diet?
Mu, Q., Zhang, H., & Luo, X. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00608 · Cited by 147
“T cell exhaustion during chronic infection may explain the ability of these pathogens to down-regulate inflammation and ameliorate SLE (49, 50).”
BackgroundKuan, P. F., Yang, X., Clouston, S., Ren, X., Kotov, R., Waszczuk, M. A., Singh, P. K., Glenn, S. T., Gomez, E. C., Wang, J., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0355-8 · Cited by 137
Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
Accapezzato, D., Caccavale, R., Paroli, M. P., Gioia, C., Nguyen, B. L., Spadea, L., & Paroli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076578 · Cited by 160
Demetriou, P., Abu‐Shah, E., Valvo, S., McCuaig, S., Mayya, V., Kvalvaag, A. S., Starkey, T., Korobchevskaya, K., Lee, L. Y. W., Friedrich, M., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0770-x · Cited by 136
The Multifaceted Role of Tissue-Resident Memory T Cells
Christo, S. N., Park, S. L., Mueller, S. N., & Mackay, L. K. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-020220 · Cited by 148
Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story
Quaglia, M., Merlotti, G., Andrea, M. D., Borgogna, C., & Cantaluppi, V. (2021) · Viruses · doi:10.3390/v13020277 · Cited by 130
PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation
Petrelli, A., Mijnheer, G., van Konijnenburg, D. P. H., van der Wal, M. M., Giovannone, B., Mocholi, E., Vazirpanah, N., Broen, J. C., Hijnen, D., Oldenburg, B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96107 · Cited by 126
SARS-CoV-2 triggering autoimmune diseases
Mobasheri, L., Nasirpour, M. H., Masoumi, E., Azarnaminy, A. F., Jafari, M., & Esmaeili, S. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155873 · Cited by 127
High-dimensional single-cell analysis reveals the immune signature of narcolepsy
Hartmann, F. J., Bernard‐Valnet, R., Queriault, C., Mrdjen, D., Weber, L. M., Galli, E., Krieg, C., Robinson, M. D., Nguyen, X., Dauvilliers, Y. A., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160897 · Cited by 124
“Precedent for broad T cell alterations in organ-specific autoimmune diseases has been reported, although the exact mechanisms involved still escape current understanding (McKinney et al., 2015).”
BackgroundAnti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
Rao, M., Valentini, D., Dodoo, E., Zumla, A. I., & Maeurer, M. J. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.01.028 · Cited by 125
“Biologically, PD-1 expression may play a beneficial role in ameliorating and curbing the development of autoimmune disease although this is not true for cancer and infections.(12) PD-1 expression on T-cells identifies immune cells that specifically recognize and react to transformed as well as to pathogen-derived anti…”
BackgroundNew Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Casalegno‐Garduño, R., & Däbritz, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738762 · Cited by 124
Taroni, J., Grayson, P. C., Hu, Q., Eddy, S. F., Kretzler, M., Merkel, P. A., & Greene, C. S. (2019) · Cell Systems · doi:10.1016/j.cels.2019.04.003 · Cited by 119
“…brushing microarray dataset (NARES dataset) that included patients with granulomatosis with polyangiitis (GPA), sarcoidosis, and healthy controls (Grayson et al., 2015) and a microarray dataset of isolated immune cell types from different autoimmune conditions (E-MTAB-2452; McKinney et al., 2015).”
BackgroundImmune aging in diabetes and its implications in wound healing
Moura, J., Madureira, P., Leal, E. C., Fonseca, A. C., & Carvalho, E. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.02.002 · Cited by 122
Giles, J. R., Manne, S., Freilich, E., Oldridge, D. A., Baxter, A. E., George, S. M., Chen, Z., Huang, H., Chilukuri, L., Carberry, M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.004 · Cited by 121
Buang, N., Tapeng, L., Gray, V., Sardini, A., Whilding, C., Lightstone, L., Cairns, T. D., Pickering, M. C., Behmoaras, J., Ling, G. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22312-y · Cited by 118
Scheerens, H., Malong, A., Bassett, K., Boyd, Z. S., Gupta, V., Harris, J. M., Mesick, C. P., Simnett, S., Stevens, H., Gilbert, H., et al. (2017) · Clinical and Translational Science · doi:10.1111/cts.12455 · Cited by 120
Thwaites, R. S., Coates, M. S., Ito, K., Ghazaly, M., Feather, C., Abdulla, F., Tunstall, T., Jain, P., Cass, L., Rapeport, G., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2567oc · Cited by 115
PD-1 immunobiology in systemic lupus erythematosus
Curran, C. S., Gupta, S., Sanz, I., & Sharon, E. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.025 · Cited by 114
T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy
Gao, Z., Feng, Y., Xu, J., & Liang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.977394 · Cited by 118
“It has also been proposed that patients with a good prognosis for each disease have their own unique set of upregulated exhaustion-associated inhibitory receptor subsets (3).”
BackgroundInfluentialMetabolic exhaustion in infection, cancer and autoimmunity
McKinney, E. F., & Smith, K. G. C. (2018) · Nature Immunology · doi:10.1038/s41590-018-0045-y · Cited by 112
Self-citationAutoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3
Grebinoski, S., Zhang, Q., Cillo, A. R., Manne, S., Xiao, H., Brunazzi, E. A., Tabib, T., Cardello, C., Lian, C. G., Murphy, G. F., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01210-5 · Cited by 107
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
Chan, K. R., Wang, X., Saron, W. A. A., Gan, E. S., Tan, H. C., Mok, D. Z. L., Zhang, S. L.-X., Lee, Y. H., Liang, C., Wijaya, L., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.164 · Cited by 102
Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy
Levi, J., Lam, T., Goth, S. R., Yaghoubi, S. S., Bates, J., Ren, G., Jivan, S., Huynh, T. L., Blecha, J. E., Khattri, R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0267 · Cited by 100
Jin, J., & Zhao, Q. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00629-y · Cited by 103
The Timing of T Cell Priming and Cycling
Obst, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00563 · Cited by 103
“Interestingly, some of them reported a dampening effect of antigen presented to CD4+ T cells repeatedly, which drives the cells into exhaustion (143), a finding with clear correlates in vivo (144) and in man (77, 145).”
BackgroundCD8+ T cells in human autoimmune arthritis: the unusual suspects
Petrelli, A., & van Wijk, F. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.74 · Cited by 97
Cellular and molecular mechanisms of CD8(+) T cell differentiation, dysfunction and exhaustion
Verdon, D. J., Mulazzani, M., & Jenkins, M. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197357 · Cited by 98
“Interestingly, TEX have been described in several autoimmune conditions, including diabetes mellitus type 1, systemic lupus erythematosus and idiopathic pulmonary fibrosis, and the extent of exhaustion and functional impairment of these cells is inversely correlated with autoimmune damage [69].”
BackgroundDesign and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis
Rao, D. A., Arazi, A., Wofsy, D., & Diamond, B. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0232-6 · Cited by 96
In vitro modeling of CD8 + T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40
Wu, J. E., Manne, S., Ngiow, S. F., Baxter, A. E., Huang, H., Freilich, E., Clark, M. L., Lee, J. H., Chen, Z., Khan, O., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade3369 · Cited by 101
Self-citationUnderstanding Human Autoimmunity and Autoinflammation Through Transcriptomics
Banchereau, R., Cepika, A., Banchereau, J., & Pascual, V. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052225 · Cited by 98
Huang, F., Thokerunga, E., He, F., Zhu, X., Wang, Z., & Tu, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02613-1 · Cited by 96
“Matrix metalloproteinase-degraded type IV collagens, Serum oncostatin M, FC and CCR9 are considered to be biomarkers of drug efficacy [93, 94], while IFN reflects disease activity [95], and the transcription signals of CD4+T and CD8+T cells are closely related to the outcome [72, 95].”
BackgroundBowman’s capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells
Chen, A., Lee, K., D’Agati, V. D., Wei, C., Fu, J., Guan, T., He, C., Schlöndorff, D., & Agudo, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97879 · Cited by 92
T cell exhaustion and immune-mediated disease — the potential for therapeutic exhaustion
McKinney, E. F., & Smith, K. G. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.005 · Cited by 91
Self-citationPawlak, M., Ho, A. W., & Kuchroo, V. K. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.09.001 · Cited by 93
Tracy, K. E., & Baumgarth, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00116 · Cited by 91
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies
Allen, M. E., Rus, V., & Szeto, G. L. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.009 · Cited by 93
“Previous transcriptomic studies highlighted the importance of type I interferon (IFN) gene expression signatures [21], immature granulocytes [22], chemokine profiles [23], and CD8+ T cells and T cell exhaustion [24, 25] in distinguishing SLE patient subsets based on disease susceptibility, activity, and severity.”
BackgroundSystems Immunology: Learning the Rules of the Immune System
Villani, A., Sarkizova, S., & Hacohen, N. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053035 · Cited by 89
“…immune responses to vaccines, or viral and bacterial infections (8−17), progression to active disease in tuberculosis (18, 19), severity of autoimmune diseases such as systemic lupus erythematosus (SLE) (20–23), as well as immune responses as a function of age, genetics, and environment (24–27).”
BackgroundQin, C., Dong, M., Zhou, L., Wang, W., Cai, S.-B., You, Y., Shang, K., Xiao, J., Wang, D., Li, C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315990121 · Cited by 85
“…disorders, recent accumulating evidence suggests that autoimmune T cell lineage and activated immune microenvironment could further contrib ute to the pathogenesis (18–20) and targeted manipulation of autoimmune T cells might lead to new therapeutic strategies for autoimmune diseases (21).”
Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes
Long, S. A., Thorpe, J., Herold, K. C., Ehlers, M. R., Sanda, S., Lim, N., Linsley, P. S., Nepom, G. T., & Harris, K. M. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.07.007 · Cited by 84
Regulators of CD8+ T cell exhaustion
Sun, Q., & Dong, C. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01221-x · Cited by 91
Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection
Beyer, M., Abdullah, Z., Chemnitz, J. M., Maisel, D., Sander, J., Lehmann, C., Thabet, Y., Shinde, P. V., Schmidleithner, L., Köhne, M., et al. (2016) · Nature Immunology · doi:10.1038/ni.3399 · Cited by 86
Metadata
- Authors
- McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- McKinney, Eoin F.
- Smith, Kenneth G. C.
- Venue
- Nature
- Published
- 2015-06-29
- Volume
- 523
- Issue
- 7562
- Pages
- 612-616
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4623162
- OpenAlex
- W2103056503
- Cited by
- 685
- References
- 56
- Citations by year
- 2026: 45 · 2025: 54 · 2024: 82 · 2023: 45 · 2022: 81 · 2021: 65 · 2020: 73 · 2019: 74 · 2018: 65 · 2017: 48 · 2016: 40 · 2015: 10
- FWCI
- 26.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (083650/Z/07/Z, 104064, 104064/Z/14/Z, 100140, 079895/Z/06/Z, 083650, 079895, 100140/Z/12/Z, 094227, 094227/Z/10/Z, 079895/Z/06/B)
- Medical Research Council (MR/L019027/1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- T cell exhaustion, CD8+ T cells, PD-1, chronic viral infection, autoimmune disease, inflammatory diseases, prognosis, hepatitis C virus, vaccine response, type 1 diabetes, systemic lupus erythematosus, antineutrophil cytoplasmic antibody-associated vasculitis, idiopathic pulmonary fibrosis, dengue hemorrhagic fever, gene expression signatures, autoreactivity
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Infections, Inflammation, Lupus Erythematosus, Systemic, Phenotype, Receptors, Antigen, T-Cell, Inflammatory Bowel Diseases, CD4-Positive T-Lymphocytes, Autoimmunity, CD8-Positive T-Lymphocytes, CD2 Antigens, Receptors, Interleukin-7, Mice, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Transcriptome, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
